Practice Patterns of Infectious Diseases Physicians in Transitioning From Intravenous to Oral Therapy in Patients With Bacteremia

Duane R Hospenthal; C Dustin Waters; Susan E Beekmann; Philip M Polgreen

doi:10.1093/ofid/ofz386

Practice Patterns of Infectious Diseases Physicians in Transitioning From Intravenous to Oral Therapy in Patients With Bacteremia

Open Forum Infect Dis. 2019 Aug 30;7(12):ofz386. doi: 10.1093/ofid/ofz386. eCollection 2020 Dec.

Authors

Duane R Hospenthal^{1

2}, C Dustin Waters³, Susan E Beekmann⁴, Philip M Polgreen⁴

Affiliations

¹ San Antonio Infectious Diseases Consultants, San Antonio, Texas.
² University of Texas Health Sciences Center at San Antonio, San Antonio, Texas.
³ Intermountain Healthcare McKay-Dee Hospital, Ogden, Utah.
⁴ Emerging Infections Network, University of Iowa, Iowa City.

Abstract

Background: Bacteremia in adult patients has traditionally been treated with extended courses of intravenous antibiotics. Data on the use of (or rapid transition to) oral therapy are limited.

Methods: Adult infectious disease physicians participating in the Infectious Diseases Society of America Emerging Infections Network (EIN) were surveyed regarding their use of oral antibiotics in patients with bacteremia. Respondents were asked to assume that patients were hemodynamically stable, recovered bacteria were susceptible to potential antibiotics, adequate source control had been achieved, and patients had adequate gastrointestinal absorption. Variables of specific bacteria, oral agent, and associated infection were included.

Results: A total of 655 (50%) of 1321 EIN participants responded. Under certain conditions, 88% would transition patients with Gram-negative bacteremia to complete a course of therapy with oral antibiotics; 71% would transition patients with Gram-positive bacteremia to oral agents. Only 78 (12%) respondents would not treat any bacteremic patient with oral agents. Most respondents (≥75%) were comfortable treating infections secondary to Enterobacteriaceae, Salmonella, Pseudomonas, Stenotrophomonas, Streptococcus pneumoniae, and β-hemolytic streptococci with oral agents. Fewer than 20% endorsed use of oral antibiotics for Staphylococcus aureus or in cases of endocarditis. Fluoroquinolones and trimethoprim-sulfamethoxazole were the preferred agents in Gram-negative bacteremia; linezolid and β-lactams were the preferred agents in Gram-positive bacteremia.

Conclusions: In select circumstances, the majority of respondents would transition patients to oral antibiotics, in both Gram-negative and Gram-positive bacteremia. Most agreed with the use of oral agents in Gram-negative bacteremia caused by Enterobacteriaceae, but they would not use oral agents for Gram-positive bacteremia caused by S aureus or in endocarditis.

Keywords: bacteremia; oral antibiotics; oral antimicrobial agents.